Anixa Biosciences (ANIX) Stock Highlights

3.45 | +0.29%

2024-09-19 06:00:15

Anixa Biosciences Inc, a cancer-focused biotechnology company, is engaged in harnessing the bodys immune system in the fight against cancer. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. It is developing the CchekTM platform, a series of inexpensive non-invasive blood tests for early detection of solid tumours which is based on the bodys immune response to the presence of a malignancy. The company is also developing chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs that genetically engineer patients own immune cells to fight cancer.

Statistics

Range Today

3.45 3.59

Volume Today 116.7K

Range 1 Year

2.15 5.13

Volume 1 Year 30.38M

Range 3 Year

2.15 6.45

Volume 3 Year 75.05M

Range 10 Year

0.6 8.09

Volume 10 Year 512.48M

Highlights

Market Capitalization 107.8M (small)

Floating Shares 30.56M

Current Price 3.45

Price To Earnings -8.56

Price To Book 4.95

Earnings Per Share -0.39

Payout Ratio 0%

Performance

Latest +0.29%

1 Month +10.22%

3 Months +34.24%

6 Months -5.99%

1 Year +5.18%

3 Years -27.06%

5 Years -19.2%

10 Years -42.5%

Benchmarks

Market Capitalization

43 / 58

Gross Profits

0 / 52

Total Revenue

56 / 57

Total Rank

35 / 58

Free Cashflow

32 / 56

Performance 5 years

29 / 58

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.